Related Experiment Video
Updated: Jun 4, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Engineered extrachromosomal oncogene amplifications promote tumorigenesis
Davide Pradella1, Minsi Zhang1,2, Rui Gao1,3
1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract:
Focal gene amplifications are among the most common cancer-associated mutations1 but have proven challenging to engineer in primary cells and model organisms. Here we describe a general strategy to engineer large (more than 1 Mbp) focal amplifications mediated by extrachromosomal DNAs (ecDNAs)2 in a spatiotemporally controlled manner in cells and in mice. By coupling ecDNA formation with expression of selectable markers, we track the dynamics of ecDNA-containing cells under physiological conditions and in the presence of specific selective pressures. We also apply this approach to generate mice harbouring Cre-inducible Myc- and Mdm2-containing ecDNAs analogous to those occurring in human cancers. We show that the engineered ecDNAs spontaneously accumulate in primary cells derived from these animals, promoting their proliferation, immortalization and transformation. Finally, we demonstrate the ability of Mdm2-containing ecDNAs to promote tumour formation in an autochthonous mouse model of hepatocellular carcinoma. These findings offer insights into the role of ecDNA-mediated gene amplifications in tumorigenesis. We anticipate that this approach will be valuable for investigating further unresolved aspects of ecDNA biology and for developing new preclinical immunocompetent mouse models of human cancers harbouring specific focal gene amplifications.
Insights
Scientists engineered large focal gene amplifications using extrachromosomal DNAs (ecDNAs) in cells and mice. This breakthrough enables studying cancer-associated mutations and developing new preclinical cancer models.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Focal gene amplifications are common cancer mutations.
- Engineering these amplifications in model systems is difficult.
Purpose of the Study:
- To develop a general strategy for engineering large focal gene amplifications using extrachromosomal DNAs (ecDNAs).
- To investigate the role of ecDNA-mediated amplifications in tumorigenesis.
- To create new preclinical models for cancer research.
Main Methods:
- Engineered large focal amplifications mediated by ecDNAs in a spatiotemporally controlled manner.
- Coupled ecDNA formation with selectable markers to track ecDNA dynamics.
- Generated mice with Cre-inducible Myc- and Mdm2-containing ecDNAs.
- Demonstrated ecDNA-driven tumor formation in a mouse model.
Main Results:
- Successfully engineered large focal amplifications using ecDNAs in cells and mice.
- Observed spontaneous ecDNA accumulation in primary cells, promoting proliferation, immortalization, and transformation.
- Showed Mdm2-containing ecDNAs promote hepatocellular carcinoma formation in mice.
Conclusions:
- The developed strategy enables controlled engineering of large focal gene amplifications via ecDNAs.
- This approach provides insights into ecDNA's role in tumorigenesis.
- The method is valuable for studying ecDNA biology and developing preclinical cancer models.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Cancers Originate from Somatic Mutations in a Single Cell
Mutagenicity and Carcinogenicity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

